ArticleCell cycle (Georgetown, Tex.)2019

Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.

Wen-Fei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.